San Franscisco, CA, United States of America

Javier Gimpel


Average Co-Inventor Count = 11.5

ph-index = 1


Location History:

  • San Franscisco, CA (US) (2022)
  • San Francisco, CA (US) (2024)

Company Filing History:


Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Javier Gimpel

Introduction

Javier Gimpel is a notable inventor based in San Francisco, California. He has made significant contributions to the field of therapeutic and diagnostic compositions, particularly targeting toll-like receptors. With a total of two patents to his name, Gimpel's work is at the forefront of medical innovation.

Latest Patents

Gimpel's latest patents include groundbreaking methods for improving conditions related to toll-like receptors. One patent focuses on therapeutic compositions and methods for enhancing TLR-related conditions. This involves determining peptide sequences associated with microorganisms, establishing binding parameters, and reengineering these sequences for therapeutic use. His other patent addresses targeted drugs associated with trimethylamine and trimeihylamine-n-oxide. This method involves administering compounds to patients to inhibit specific enzymes linked to certain microorganisms.

Career Highlights

Gimpel's career is marked by his dedication to advancing medical science through innovative solutions. His work has the potential to impact various health conditions significantly. He is associated with Psomagen, Inc., where he continues to develop his ideas and inventions.

Collaborations

Gimpel collaborates with talented individuals such as Zachary Apte and Jessica Richman. Their combined expertise fosters a creative environment that enhances the development of innovative solutions in their field.

Conclusion

Javier Gimpel's contributions to the field of therapeutics and diagnostics exemplify the spirit of innovation. His patents reflect a commitment to improving health outcomes through scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…